Conference call to be Held at 9:00 a.m. Eastern Time Today, May 26, 2009 SILVER SPRING, Md., May 26 (HSMN NewsFeed) — United Therapeutics Corporation (Nasdaq: UTHR ) announced today that the United States Food and Drug Administration (FDA) has approv…
Biopharmaceuticals, FDA
United Therapeutics, ADCIRCA, tadalafil, pulmonary arterial hypertension

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension”
Leave a Comment